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To the Editors,
We read with interest the recent manuscript of
Gleicher, et al. regarding their statement that we de-
scribed a mosaicism rate of 40%; it is presumed that this
conclusion was derived from our report that two of five
miscarried embryos (of 525 diagnosed euploid single
thawed embryo transfers) were misdiagnosed, which was
identified upon reanalysis of biopsied specimens [1].
Our manuscript did not intend (nor was it designed) to
assess the mosaicism rate of blastocysts diagnosed by
aCGH of trophectoderm biopsies.
Data shows that infants born from in vitro fertilization
have low mosaicism rates. NGS-diagnosed euploid
trophectoderm samples have been reanalyzed in at least
124 embryos showing 100% euploidy concordance [2–4].
Gleicher, et al. excluded our 280 normal deliveries from
the denominator in their extrapolation of our data
secondary to the possibility that these infants were de-
rived from mosaic embryos [1]. This exclusion is mis-
leading. To assume that 40% of the infants delivered
were derived from self-corrected mosaic embryos is
equally misleading.
Our data never intended to evaluate mosaicism rates in
embryos, and citing our data in such a way misrepresents
our findings. We suggest that instead, the authors should
perform experiments to determine the rate of mosaicism
experimentally. This should potentially include repeat bi-
opsy of embryos at multiple sites, including the inner cell
mass, and subsequently analyzing biopsied specimens using
a systemic, validated assay. We are aware of several manu-
scripts in various stages of the peer review process that
actually address this specific question and report rates
much lower than the rates that the authors inaccurately
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